SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-071917
Filing Date
2013-09-24
Accepted
2013-09-24 17:28:16
Documents
8
Period of Report
2013-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-21122_38k.htm 8-K 39580
2 EX-1.1 a13-21122_3ex1d1.htm EX-1.1 258236
3 EX-5.1 a13-21122_3ex5d1.htm EX-5.1 9110
4 EX-23.2 a13-21122_3ex23d2.htm EX-23.2 4496
5 EX-99.1 a13-21122_3ex99d1.htm EX-99.1 9847
6 GRAPHIC g211223mmi001.jpg GRAPHIC 3845
7 GRAPHIC g211223kmi001.jpg GRAPHIC 2082
8 GRAPHIC g211223kki001.jpg GRAPHIC 2314
  Complete submission text file 0001104659-13-071917.txt   334211
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 131112896
SIC: 2836 Biological Products, (No Diagnostic Substances)